	Carcinoma InÂ Situ Skip Lesions of the Uterine Corpus in Cervical Squamous Cell Carcinoma: Impact on Target Setting in Radiotherapy. Cancer Rep (Hoboken) Harada M, Hagiwara Y, Kabasawa T, Sato H, Ichikawa M, Akamatsu H, Kaneko T, Yano N, Uematsu K, Komatsu M, Tanae T, Nemoto K, Koto M. PMID: 42985977 [PubMed - indexed for MEDLINE]
	Single-Cell and Spatial Insights into Oral Squamous Cell Carcinoma: Towards Cell-State-Targeted Immunotherapy. Oncol Res Chen Y, Hou L. PMID: 42984972 [PubMed - indexed for MEDLINE]
	Multiple sources, shared readouts: the attribution gap in circular RNA immunotherapy for esophageal squamous cell carcinoma. Front Immunol Li Z, Wang J, Lv H, Zhang F, Sun B, Huang C, Liu Z, Tian Z. PMID: 42984690 [PubMed - indexed for MEDLINE]
	Tumor budding and tumor-associated lymphocytic response as histopathological indicators of high-risk disease in head and neck cutaneous squamous cell carcinoma. BMC Cancer Aksu D, Yalç, Karasu N, Kuzu S, Özdemir Ç, Aksu U. PMID: 42983664 [PubMed - indexed for MEDLINE]
	Tumor-stromal ratio as a predictive marker for lymph node metastasis in patients with oral cavity squamous cell carcinoma: a cross-sectional study. BMC Cancer Muthuvel R, Saheb MIM, A N G, M SK. PMID: 42983321 [PubMed - indexed for MEDLINE]
	Neoadjuvant pepinemab in combination with nivolumab and/or ipilimumab in resectable metastatic melanoma: a pilot biomarker-driven trial. Nat Commun Ruffin AT, Mallow CL, Olson BM, Hammons J, Melendez B, Chelvanambi M, Gersz EM, Wittling MC, Diggs LP, Reilly C, Switchenko JM, Lazar AJ, Swisher SK, Kim J, Burns B, Harutyunyan A, Fisher TL, Delman KA, Yushak ML, Parker DC, Lawson D, Wargo JA, Zauderer M, Evans EE, Paulos CM, Lowe MC, Lesinski GB. PMID: 42982815 [PubMed - indexed for MEDLINE]
	Explainable computational framework for subtype classification and biomarker identification in head and neck squamous cell carcinoma using machine learning. PLoS One Rajan A, Biji CL, Sinha MG, Oviya IR. PMID: 42981280 [PubMed - indexed for MEDLINE]
	Therapeutic Hybrid Intelligence with Neural and Knowledge-based Expert Reasoning for SRS (THINKERS): an AI model for melanoma brain metastases. Neurosurg Rev Reyes JS, Bouras A, Lunsford LD, Niranjan A, Hadjipanayis CG. PMID: 42980889 [PubMed - indexed for MEDLINE]
	M0K0 M1K1 Grading System for Oral Squamous Cell Carcinoma - A Retrospective Study. Indian J Dent Res Natarajan S, Nandita KP, Boaz K, Lewis A, Manaktala N, Pai S. PMID: 42980262 [PubMed - indexed for MEDLINE]
	EDRIC-associated immune injury correlates with one-third of the survival detriment of elective nodal irradiation in esophageal squamous cell carcinoma. Front Immunol Ren X, Li L, Fan X, Zhu S, Yang H, Deng W, Liu L, Han C, Wang L. PMID: 42979186 [PubMed - indexed for MEDLINE]
	Closing the adaptive window: immune-metabolic strategies to constrain melanoma therapy resistance. Front Immunol Riccardo F, Conti L, Defilippi P, Arina P, Audrito V, Calautti E. PMID: 42979158 [PubMed - indexed for MEDLINE]
	Cutaneous metastasis in laryngeal squamous cell carcinoma: a case report and review of the literature. J Med Case Rep Zhang X, Lv H, Zou Y, Zhao H, Liu J. PMID: 42978003 [PubMed - indexed for MEDLINE]
	Regulatable membrane-bound IL-15 engineered TIL cell therapy for immune checkpoint inhibitor-resistant advanced melanoma: pooled analysis of phase 1 and 1/2 trials. Nat Med Amaria RN, Chesney JA, Betof AS, In GK, Shoushtari AN, Johnson TT, Hamid O, Samhouri Y, Davies MA, Tawbi HA, Glitza Oliva IC, Aksoy BA, Kelly AM, Duan R, Prabhakar P, Ramsingh G, Jagasia M, Hari P. PMID: 42977756 [PubMed - as supplied by publisher]
	Acral melanoma: a unique subtype requiring unique solutions. Trends Cancer Possik PA, Robles-Espinoza CD, Adams DJ, Rebecca VW, Yeh I, Robertson GP, Couts KL, Smalley KSM, Judson-Torres RL, Aplin AE, Neumann NM, Semenov YR, In GK, Levy J, Hurlbert MS, Acral Melanoma Research Consortium, Bastian B, White R, Villanueva J. PMID: 42977670 [PubMed - as supplied by publisher]
	[Cervical lymph node metastasis as the initial presentation of poorly differentiated esophageal carcinoma mimicking breast origin: a diagnostic challenge]. Rev Gastroenterol Peru Ayala Antonio MJ, Velita Miranda NK, Huiza Centeno XL, Torres-Salinas C. PMID: 42977284 [PubMed - indexed for MEDLINE]
	Evaluating the Clinical Efficacy, Utility, and Role of the 40-Gene Expression Profiling Test in Assessing Prognosis of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel. J Drugs Dermatol Burshtein J, Rosenberg A, Arron ST, Bartley B, Cotter D, Desai SR, DeBusk L, Farberg A, Nguyen HP, Schlesinger T, Shah M, Zakria D, Zeitouni N, Rigel D. PMID: 42976841 [PubMed - indexed for MEDLINE]
	Immunosuppressive and Immunomodulatory Dermatologic Therapies: Cancer Risk for Patients With Active or Prior Malignancy. J Drugs Dermatol Khuhro A, Kaufman L, Kobayashi S. PMID: 42976837 [PubMed - indexed for MEDLINE]
	Increased Risk of Skin Cancers in Certain Occupations. J Drugs Dermatol Meledathu S, Noda I, Mitre M, Ashinoff R. PMID: 42976832 [PubMed - indexed for MEDLINE]
	Can Esophagectomy be Safely Avoided After Clinical Complete Response in Esophageal Squamous Cell Carcinoma? Response Assessment, Active Surveillance, and Salvage in the Immunotherapy Era. Curr Oncol Rep Sagawa T, Hirakawa M, Nagashima H, Fujikawa K. PMID: 42975733 [PubMed - indexed for MEDLINE]
	A Review of the Use of Ex-Vivo Confocal Microscopy in the Management of Non-Melanoma Skin Cancers. Dermatol Surg Alladeen A, Vijayvargiya N, Anumolu A, Mahadeo S, Minkis K. PMID: 42975558 [PubMed - as supplied by publisher]

Articles 1 - 20 / 145610

Page 1 of 7281



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy